Clinical Trials Logo

Clinical Trial Summary

The study was designed as a prospective, multicenter, randomized, open-label, parallel-controlled clinical trial. The study population was patients with vulvar leukoplakia, and compared the efficacy and safety of AI temperature-controlled radio frequency technology and electrical stimulation in the treatment of vulvar leukoplakia. According to the research purpose, the sample size was calculated and determined to be 120 cases, and they were randomly assigned to the observation group and the control group according to the ratio of 1:1, namely 60 cases in the radio frequency observation group and 60 cases in the electric stimulation control group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05250466
Study type Interventional
Source Zhongnan Hospital
Contact Yuanzhen Zhang, professor
Phone +86 13545364853
Email wdzn2019@163.com
Status Recruiting
Phase N/A
Start date July 7, 2022
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03961126 - Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma. Phase 2
Completed NCT03686800 - The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients N/A
Completed NCT05147129 - Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus
Completed NCT02573883 - Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus Phase 3
Recruiting NCT06132919 - Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) Phase 2
Completed NCT04952961 - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study N/A
Terminated NCT01126255 - Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus Phase 2
Recruiting NCT04951206 - Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus Phase 4
Active, not recruiting NCT03926299 - Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT04148651 - The CO2RE® System for Vulvar Lichen Sclerosus N/A
Completed NCT02416531 - Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser N/A
Recruiting NCT04967170 - A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus Phase 1/Phase 2
Terminated NCT04134494 - Laser Treatment for Vulvar Lichen Sclerosus N/A
Completed NCT05251220 - Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Completed NCT01400022 - Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus N/A
Recruiting NCT06360705 - StrataMGT for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT00757874 - Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus Phase 2
Recruiting NCT05243563 - Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone? Phase 2/Phase 3